As of August 28, 2026, Editas Medicine, Inc. (EDIT) has a DilutionWatch DilutionScore of 48/100, rated MEDIUM dilution risk. Editas Medicine, Inc. has a market capitalization of $530.98M, 153.58M shares outstanding, 209 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for EDIT.
Market Data
Market Cap$530.98M
Shares Outstanding153.58M
Float97.73M
Cash$211.65M
Debt$55.74M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 23.4% shares (2026Q1 vs prior)
209 institutional holders · 64.52M shares
#1
BlackRock, Inc.
9.26M shares
#2
VANGUARD CAPITAL MANAGEMENT LLC
8.41M shares
#3
RENAISSANCE TECHNOLOGIES LLC
3.97M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest23.46M
Days to Cover18.2
% of Float24.0%
FINRA data as of Jul 31, 2026
Recent SEC Activity
4
INSIDER TRANSACTION
2026-03-04
4
INSIDER TRANSACTION
2026-03-04
4
INSIDER TRANSACTION
2026-03-04
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual EDIT Dilution Snapshot
Editas Medicine, Inc. (EDIT) has a DilutionScore of 48/100, rated Medium dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for EDIT: 4 on 2026-03-04; 4 on 2026-03-04; 4 on 2026-03-04.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track EDIT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking EDIT — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for EDIT
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.